Compile Data Set for Download or QSAR
maximum 50k data
Found 111 Enz. Inhib. hit(s) with all data for entry = 9086
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439415((S)-4-(4-(tert-butoxy)-2-(4-(5-chloro-2-propionylp...)
Affinity DataIC50:  12nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439331((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  13nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439330((S)-4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy...)
Affinity DataIC50:  14nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439325((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  16nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439328(4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy-2-o...)
Affinity DataIC50:  17nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439418((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  18nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439322((S)-5-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  19nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439344((S)-4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy...)
Affinity DataIC50:  21nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439373((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  21nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439396((S)-4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy...)
Affinity DataIC50:  21nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439408((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  23nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439340(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  24nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439398((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  24nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439421((S)-4-(tert-butoxy)-2-(4-(5-chloro-2-propionylphen...)
Affinity DataIC50:  27nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439415((S)-4-(4-(tert-butoxy)-2-(4-(5-chloro-2-propionylp...)
Affinity DataIC50:  27nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439349((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  29nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439405(4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy-2-o...)
Affinity DataIC50:  29nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439350(N-(1H-benzo[d]imidazol-5-yl)-2-(4-(5-chloro-2-prop...)
Affinity DataIC50:  30nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439414((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  30nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439447((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  30nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439325((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  31nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439401(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyri...)
Affinity DataIC50:  32nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439420(4-(tert-butoxy)-2-(4-(5-chloro-2-propionylphenyl)-...)
Affinity DataIC50:  33nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439438(4-(2-(4-(6-acetyl-3-chloro-2-fluorophenyl)-5-metho...)
Affinity DataIC50:  33nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439321(5-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  34nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439327(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  34nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439364(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  34nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439365(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  35nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439406(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  35nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439444(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  35nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439451((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  35nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439338((S)-2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxo...)
Affinity DataIC50:  36nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439339(4-(2-(4-(2-butyryl-5-chlorophenyl)-5-methoxy-2-oxo...)
Affinity DataIC50:  36nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439341(4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy-2-o...)
Affinity DataIC50:  36nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439403(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyri...)
Affinity DataIC50:  36nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439432(4-(2-(4-(6-acetyl-3-chloro-2-fluorophenyl)-5-metho...)
Affinity DataIC50:  37nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439351(4-(2-(4-(5-chloro-2-(2-cyclopropylacetyl)phenyl)-5...)
Affinity DataIC50:  38nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439352(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyri...)
Affinity DataIC50:  38nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439324(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  39nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439353(4-(2-(4-(5-chloro-2-(cyclopropanecarbonyl)phenyl)-...)
Affinity DataIC50:  39nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439354(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyri...)
Affinity DataIC50:  40nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439380((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  40nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439404(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxopyri...)
Affinity DataIC50:  40nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439332(US10633375, Compound No. 12 | US11084808, Compound...)
Affinity DataIC50:  42nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439384((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  42nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439393((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  42nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439397(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  42nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439448(4-(2-(4-(5-chloro-2-propionylphenyl)-5-methoxy-2-o...)
Affinity DataIC50:  42nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439363(4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-oxop...)
Affinity DataIC50:  43nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Jinagsu Hengrui Medicine

US Patent
LigandPNGBDBM439450((S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-5-methoxy-2-...)
Affinity DataIC50:  43nMAssay Description:Test Example 1: Biological Activity of the Compounds of the Present Invention onThe Inhibition of Factor XIa Detected by Absorption Photometry1. Expe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 111 total ) | Next | Last >>
Jump to: